Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma

por Peng, Jian-Heng, Zhang, Xiang, Song, Jun-Long, Ran, Liang, Luo, Rong, Li, Hong-Yuan, Wang, Yong-Hong
Publicado 2019